Onevista,
While the immunotherapy drugs are new, and just now starting to leak results from real world studies, the trend is looking positive, to my view.
On this board, use the menu system to go to MENU, FORUMS, SEARCH and enter the keyword KEYTRUDA. You can then read past posts about Keytruda. Keytruda is one of the immuno-drugs. One of the most recent comments (from a member) reports of a positive result in a situation sounding similar to yours.
A couple of my posts are there also. I was concerned of over-hype based the limited studies released, and on what appear to be source bias. A lot happens in biotech in a short time. I *think* there are positive signs. It is a simple fact that real-world long term results take a long time to produce.
The January 2, 2018 industry report - outsider report - in 'FierecBiotech' and industry review newsletter, describes the current state of bio-drugs we see in bladder lung cancers. While the link below is NOT a science report, nor is it a technical report, it IS a review of the very recent COMPARISON, by recognized industry watchers, describing the state of a segment of the imuno-drug industry. I believe that reports such as this are pointing to positive results about to be released.
www.fiercepharma.com/pharma/2018-here-now-get-ready-for-market-defining-i-o-readouts
If it helps, I hope for positive results for your situation, and for mine, if/when i move to that next stage where immuno-drugs may be the next option.
Best
Jack